We are live on
!
Find out more
MF
Magnetar Financial Portfolio holdings
AUM
$9.84B
1-Year Est. Return
190.64%
This Fund
S&P 500
This Quarter
Est. Return
+6.33%
1 Year Est. Return
+190.64%
3 Year Est. Return
+293.18%
5 Year Est. Return
+491.79%
10 Year Est. Return
+5,174.28%
AUM
$4.62B
AUM Growth
-$179M
(-3.7%)
Cap. Flow
-$2.12B
Cap. Flow
% of AUM
-45.83%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
756
New
266
Increased
123
Reduced
74
Closed
249
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$71M |
| 2 |
McKesson
MCK
|
+$54.9M |
| 3 |
TELL
Tellurian Inc.
TELL
|
+$41.7M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$39.6M |
| 5 |
AstraZeneca
AZN
|
+$38.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$139M |
| 2 |
Zimmer Biomet
ZBH
|
+$125M |
| 3 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$89.5M |
| 4 |
Becton Dickinson
BDX
|
+$87M |
| 5 |
Abbott
ABT
|
+$85.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.44% |
| 2 | Technology | 10.1% |
| 3 | Energy | 7.35% |
| 4 | Financials | 6.6% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
NewtekOne
NEWT
$423M
| $171K | ﹤0.01% |
+13,752
| New | +$174K |
|
|
HAPN
452
Happen Inc
HAPN
$2.23B
| $170K | ﹤0.01% |
14,891
-7,963
| -35% | -$85K |
|
453
Accel Entertainment
ACEL
$973M
| $170K | ﹤0.01% |
+14,626
| New | +$161K |
|
454
Yext
YEXT
$552M
| $170K | ﹤0.01% |
+24,521
| New | +$136K |
|
455
Western Union
WU
$2.4B
| $165K | ﹤0.01% |
+13,825
| New | +$167K |
|
456
Freshworks
FRSH
$3.11B
| $148K | ﹤0.01% |
+12,895
| New | +$155K |
|
457
Regenxbio
RGNX
$648M
| $143K | ﹤0.01% |
+13,603
| New | +$166K |
|
458
BioCryst Pharmaceuticals
BCRX
$2.35B
| $136K | ﹤0.01% |
+17,928
| New | +$136K |
|
459
New Fortress Energy
NFE
$94.6M
| $130K | ﹤0.01% |
+14,340
| New | +$221K |
|
|
MCW
460
DELISTED
Mister Car Wash
MCW
| $118K | ﹤0.01% |
+18,076
| New | +$122K |
|
|
KW
461
DELISTED
Kennedy-Wilson Holdings
KW
| $114K | ﹤0.01% |
+10,334
| New | +$110K |
|
|
CGAU
462
Centerra Gold
CGAU
$3.58B
| $107K | ﹤0.01% |
+14,900
| New | +$102K |
|
463
Zura Bio
ZURA
$526M
| $101K | ﹤0.01% |
+24,827
| New | +$92.8K |
|
464
Theravance Biopharma
TBPH
$873M
| $98.2K | ﹤0.01% |
+12,183
| New | +$106K |
|
|
HDSN
465
Hudson Technologies
HDSN
$244M
| $91.5K | ﹤0.01% |
+10,967
| New | +$90.7K |
|
|
ZUO
466
DELISTED
Zuora, Inc.
ZUO
| $90.9K | ﹤0.01% |
+10,543
| New | +$93.5K |
|
467
Acco Brands
ACCO
$390M
| $90K | ﹤0.01% |
+16,445
| New | +$83.1K |
|
468
Brookdale Senior Living
BKD
$3.49B
| $74.2K | ﹤0.01% |
+10,934
| New | +$78K |
|
|
CMRC
469
Commerce.com Inc Series 1
CMRC
$261M
| $67.4K | ﹤0.01% |
+11,521
| New | +$76K |
|
470
TriSalus Life Sciences
TLSI
$280M
| $65.6K | ﹤0.01% |
+14,232
| New | +$75.4K |
|
471
Volato Group
SOAR
$7.04M
| $57.2K | ﹤0.01% |
+6,164
| New | +$72.1K |
|
|
BARK.WS
472
DELISTED
BARK Inc Warrants
BARK.WS
| $54K | ﹤0.01% |
600,114
-152,040
| -20% | -$11.8K |
|
473
Evolv Technologies
EVLV
$986M
| $48.7K | ﹤0.01% |
+146,587
| New | +$512K |
|
474
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $45.6K | ﹤0.01% |
134,100
-1,197,000
| -90% | -$662M |
|
|
AMOD
475
Alpha Modus Holdings
AMOD
$18.2M
| $32.1K | ﹤0.01% |
+938
| New | +$425K |
|
Similar funds
HI
MPI
URS
FPAS
CCM
FCM
HL
DCP
Magnetar Financial's Q3 2024 Portfolio in Review
As of Q3 2024, Magnetar Financial held 756 positions worth $4.62B, down 3.7% from $4.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Magnetar Financial withdrew a net $2.12B in Q3 2024, closing 249 positions and reducing 74 holdings. Its most notable exit was Novartis, an estimated $139M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 48% a quarter earlier, followed by Technology and Energy.
Against the trend, Magnetar Financial opened a new position in Kellanova worth $80.5M.
- Magnetar Financial's largest Q3 2024 buy was Kellanova: 997,792 shares worth $80.5M.
- Magnetar Financial added most to McKesson in Q3 2024, an estimated $54.9M increase.
- Magnetar Financial's biggest Q3 2024 reduction was Zimmer Biomet, cutting an estimated $125M.
- Magnetar Financial fully exited Novartis in Q3 2024, selling an estimated $139M.
- Magnetar Financial's ten largest holdings make up 21% of its $4.62B portfolio in Q3 2024.
- Magnetar Financial opened 266 new positions and closed 249 in Q3 2024.
- Magnetar Financial's portfolio value fell 3.7% quarter-over-quarter to $4.62B.
Based on Magnetar Financial's 13F filing for Q3 2024, filed 13 Nov 2024.